Document is current
Any future updates will be listed below
-
Authors
Cullen, Róisín
Nayak, Kirtana Jagadeesh
Singh, Dave
Beech, Augusta https://orcid.org/0000-0002-2690-5364
Vyas, Avni
- License Information
-
More Information
Article History
Received: 3 December 2025
Accepted: 17 February 2026
First Online: 18 March 2026
Declarations
:
: RC, KN, AB and AV have no COI. DS has received personal fees from Adovate, Aerogen, Almirall, Apogee, Arrowhead, AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, Cipla, CONNECT Biopharm, Covis, CSL Behring, DevPro Biopharma LCC, Elpen, Empirico, EpiEndo, Genentech, Generate Biomedicines, GlaxoSmithKline, Glenmark, Kamada, Kinaset Therapeutics, Kymera, Menarini, MicroA, OM Pharma, Orion, Pieris Pharmaceuticals, Pulmatrix, Revolo, Roivant Sciences, Sanofi, Synairgen, Tetherex, Teva, Theravance Biopharma, Upstream and Verona Pharma.
